These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27133910)

  • 1. [Resynchronization therapy in Catalonia, Spain: Cost effectiveness of beating together or separately].
    Pastor P; Zamorano JL
    Med Clin (Barc); 2016 May; 146(10):440-2. PubMed ID: 27133910
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National Institute for Health and Care Excellence 2014 guidance on cardiac implantable electronic devices: health economics reloaded.
    Leyva F; Plummer CJ
    Europace; 2015 Mar; 17(3):339-42. PubMed ID: 25722476
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac Pacing and Defibrillation Devices: Cost and Effectiveness.
    Groeneveld PW; Dixit S
    Annu Rev Med; 2017 Jan; 68():1-13. PubMed ID: 27686020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy: a cost or an investment?
    Boriani G; Mantovani LG; Biffi M; Schalij MJ; Martignani C; Leclercq C; Bax JJ; Auricchio A
    Europace; 2011 May; 13 Suppl 2():ii32-8. PubMed ID: 21518747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remote monitoring: a cost or an investment?
    Burri H; Heidbüchel H; Jung W; Brugada P
    Europace; 2011 May; 13 Suppl 2():ii44-8. PubMed ID: 21518749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.
    Mairesse GH; Braunschweig F; Klersy K; Cowie MR; Leyva F
    Europace; 2015 May; 17(5):814-8. PubMed ID: 25713012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?
    Boriani G
    Europace; 2015 May; 17(5):674-6. PubMed ID: 25805157
    [No Abstract]   [Full Text] [Related]  

  • 9. The Burden of Cardiac Rhythm Management Complications.
    Andrikopoulos GK
    Hellenic J Cardiol; 2016; 57(1):39-40. PubMed ID: 26856200
    [No Abstract]   [Full Text] [Related]  

  • 10. Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario.
    Boriani G; Burri H; Mantovani LG; Maniadakis N; Leyva F; Kautzner J; Lubinski A; Braunschweig F; Jung W; Lozano IF; Fattore G
    Europace; 2011 May; 13 Suppl 2():ii59-65. PubMed ID: 21518752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of community wealth on use of cardiac-resynchronization therapy with defibrillators for heart failure patients.
    Farmer SA; Tuohy EJ; Small DS; Wang Y; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):798-807. PubMed ID: 23093561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of cardiac resynchronization therapy in Greece: an analysis based on the CArdiac REsychronization in Heart Failure trial.
    Maniadakis N; Ekman M; Calvert MJ; Freemantle N; Karamalis M; Vardas P
    Europace; 2011 Nov; 13(11):1597-603. PubMed ID: 21821852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspective on cost-effective utilization of cardiac resynchronization therapy.
    Lindsay BD
    J Cardiovasc Electrophysiol; 2013 Jan; 24(1):75-6. PubMed ID: 23131045
    [No Abstract]   [Full Text] [Related]  

  • 14. Arrhythmia care in a value-based environment: Past, present, and future: Developed and endorsed by the Heart Rhythm Society (HRS).
    Kusumoto FM; Hao SC; Slotwiner DJ; Cheung JW; Hsu JC; Kowalski M; Madden RA; Mason PK; Mendenhall GS; Nair DG; Nasir JM; Silverstein JR; Sutton B; Tarakji KG; Upadhyay GA; Zeitler EP
    Heart Rhythm; 2018 Feb; 15(2):e5-e15. PubMed ID: 29254674
    [No Abstract]   [Full Text] [Related]  

  • 15. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 16. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
    Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
    Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of intraoperative electrical parameters obtained during implantation of cardiac resynchronization therapy devices for the prediction of reverse remodeling.
    de Riva-Silva M; López-Gil M; Salgado-Aranda R; Fontenla-Cerezuela A; Salguero-Bodes R; Arribas-Ynsaurriaga F
    Rev Esp Cardiol (Engl Ed); 2014 Oct; 67(10):855-7. PubMed ID: 25262137
    [No Abstract]   [Full Text] [Related]  

  • 18. Cost-effectiveness analysis of cardiac resynchronization therapy in patients with NYHA I and NYHA II heart failure in Spain.
    Almenar L; Díaz B; Quesada A; Crespo C; Martí B; Mealing S; Linde C; Daubert C
    Int J Technol Assess Health Care; 2013 Apr; 29(2):140-6. PubMed ID: 23552131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economic evaluation of single-lead atrial pacing vs. dual-chamber pacing in sick sinus syndrome.
    Oddershede L; Riahi S; Nielsen JC; Hjortshøj S; Andersen HR; Ehlers L
    Europace; 2014 Jun; 16(6):866-72. PubMed ID: 24451290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac resynchronisation therapy in patients with atrioventricular nodal disease and reduced ejection fraction - can we afford it?
    Pathik B; Mathew T; Chahadi F; Sutton K; McGavigan AD
    Heart Lung Circ; 2015 Apr; 24(4):354-8. PubMed ID: 25488381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.